A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients – ZAP2
Số trang: 12
Loại file: pdf
Dung lượng: 663.15 KB
Lượt xem: 18
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Bisphosphonates are a class of drugs that slow bone loss and are a promising candidate to treat knee osteoarthritis (OA) patients. In a pilot study, we demonstrated that zoledronic acid reduced knee pain and size of subchondral bone marrow lesions (BMLs) over 6 months in knee OA patients with significant knee pain and BMLs.
Nội dung trích xuất từ tài liệu:
A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients – ZAP2
Nội dung trích xuất từ tài liệu:
A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients – ZAP2
Tìm kiếm theo từ khóa liên quan:
BMC Musculoskeletal Disorders Zoledronic acid Magnetic resonance imaging Promising candidate Treat knee osteoarthritisTài liệu liên quan:
-
Ebook Atlas of small animal diagnostic imaging: Part 1
405 trang 45 0 0 -
Ebook Fowler's zoo and wild animal medicine (Vol 8 - 1st Edition): Part 2
374 trang 39 0 0 -
Ebook A first Introduction to quantum physics: Part 1
119 trang 28 0 0 -
Ebook Diagnostic MRI in dogs and cats: Part 1
423 trang 27 0 0 -
Predicting short stay total hip arthroplasty by use of the timed up and go-test
7 trang 26 0 0 -
12 trang 25 0 0
-
10 trang 24 0 0
-
12 trang 24 0 0
-
Risk factors for musculoskeletal pain amongst nurses in Estonia: A cross-sectional study
7 trang 23 0 0 -
6 trang 21 0 0